Navigation Links
Probiotic Delivery Technology Awarded Third International Patent

REDMOND, Wash., Dec. 16 /PRNewswire/ -- The Australian Patent Office has issued Nutraceutix, Inc. a patent for BIO-tract. It is the third international patent, from many patents pending, that the technology has been awarded based on BIO-tract's ability to protect sensitive ingredients like probiotic organisms from stomach acid on their way to optimal release sites in the intestinal tract.

Steve Moger, President and CEO of Nutraceutix comments: "Many years ago, we recognized the need for an effective probiotic and nutraceutical delivery technology -- one that draws from proven pharmaceutical principals, but does so in a fashion that is economically feasible in the nutritional supplement marketplace. With BIO-tract, we have addressed this need."

In the case of probiotics, three critical barriers must be overcome to fully benefit the consumer.

    --  Survival of these beneficial, but fragile organisms through the
        manufacturing process
    --  Survival on the store shelf
    --  Safe passage through the harsh stomach acids that may denature the

BIO-tract products incorporate proven processes and technologies to overcome these barriers.

How BIO-tract works

Once ingested, BIO-tract tablets form a protective layer, which shields probiotic organisms from the acidic conditions of the stomach. After passing from the stomach to the intestinal tract, the tablets release the organisms at optimal rates determined by formulation.

Broad applications for BIO-tract

Application of the BIO-tract delivery system is not limited to probiotics. It has been applied to many other ingredients that benefit from effective gastric acid protection, buffering, controlled release and once-daily dosing. Custom BIO-tract formulations allow the controlled release of active ingredients at rates ranging from just a few hours to all day long.

Nutraceutix celebrates 25 years of manufacturing excellence

Based in Redmond, Washington, Nutraceutix, Inc. is celebrating its 25th year of manufacturing excellence as a probiotics and nutritional supplements company. Nutraceutix supplies natural probiotic strains and incorporates patented LiveBac(R) shelf-life enhancements and a variety of delivery technologies into custom probiotic products for clients. Nutraceutix also custom formulates and contract manufactures premium controlled-release nutraceuticals that offer enhanced bioavailability, reduced side effects and improved dose compliance. Nutraceutix produces bulk probiotic powders, and manufactures capsules and advanced tablets in bulk or finished bottles in its NSF certified GMP contract manufacturing facility.

SOURCE Nutraceutix
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
2. New Young Investigator Grants for Probiotics Research Announced
3. Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research
4. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
5. Main Street Gourmet Launches New Probiotic Muffins
6. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
7. Turtle Island Soup Gets Souped Up with New Probiotic, GandenBC30
8. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
9. Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research
10. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
11. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is one ... biomarkers market with pharmaceutical companies and diagnostic ... diagnostic tests. . ... Complete report on global cancer biomarkers market ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015 Daon, a global leader ... has released a new version of its IdentityX ... North America have already installed IdentityX ... includes a FIDO UAF certified server component ... to activate FIDO features. These customers include some of ...
(Date:10/29/2015)... 29, 2015 Today, LifeBEAM , ... with 2XU, a global leader in technical performance ... hat with advanced bio-sensing technology. The hat will ... monitor key biometrics to improve overall training performance. ... two companies will bring together the most advanced technology, ...
(Date:10/26/2015)... , October 26, 2015 /PRNewswire/ ... --> adds Biometrics ... to 2021 as well as Emerging ... research reports to its collection of ... . --> ...
Breaking Biology News(10 mins):